Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...
After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...
Novartis said the U.S. Food and Drug Administration has approved the use of Pluvicto against a certain type of prostate cancer. The drug maker said Friday that the FDA green-lit the use of Pluvicto to ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...
1d
Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forwardRaanana, Israel, ...
Exelixis (EXEL) wins FDA approval for Cabometyx for advanced pancreatic and extra pancreatic neuroendocrine tumors in ...
Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...
President Trump’s approval rating has steadily declined since the start of his second term, according to a new Quinnipiac University poll highlighting growing voter dissatisfaction with his ...
The FDA is expected to decide on treatments for dry eye disease ... absorption and robust efficacy compared with existing DHE products. The Company is seeking approval for acute treatment of migraine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback